Aspen Pharmacare Price to Book Ratio 2017-2023 | APNHY
Historical price to book ratio values for Aspen Pharmacare (APNHY) over the last 10 years. The current price to book ratio for Aspen Pharmacare as of May 01, 2024 is 1.10.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Aspen Pharmacare Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
0.00 | nan |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical - Generic Drugs | $5.328B | $2.296B |
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Teva Pharmaceutical Industries (TEVA) | Israel | $15.673B | 5.66 |
Dr Reddy's Laboratories (RDY) | India | $12.346B | 19.52 |
BridgeBio Pharma (BBIO) | United States | $5.058B | 0.00 |
Bausch Health Cos (BHC) | Canada | $3.197B | 2.49 |
Amphastar Pharmaceuticals (AMPH) | United States | $2.056B | 14.07 |
Supernus Pharmaceuticals (SUPN) | United States | $1.654B | 0.00 |
Taysha Gene Therapies (TSHA) | United States | $0.453B | 0.00 |
Generation Bio (GBIO) | United States | $0.193B | 0.00 |
Personalis (PSNL) | United States | $0.078B | 0.00 |
Assembly Biosciences (ASMB) | United States | $0.073B | 0.00 |
Acasti Pharma (ACST) | Canada | $0.027B | 0.00 |
Sol-Gel Technologies (SLGL) | Israel | $0.022B | 0.00 |
Evoke Pharma (EVOK) | United States | $0.004B | 0.00 |
Teligent (TLGT) | United States | $0.000B | 0.00 |